Tamiflu şi BioR &icirc;n tratamentul pacienţilor cu gripă A (H1N1)

Pantea Valeriu; Rudic Valeriu; Spânu Constantin; Cebotarescu Valentin; Cojuhari Lilia; Jimbei Paulina; Deatişen Victor

Conţinutul numărului revistei

Articolul precedent

Articolul urmator

602

SM ISO690:2012

PANTEA, Valeriu, RUDIC, Valeriu, SPÂNU, Constantin, CEBOTARESCU, Valentin, COJUHARI, Lilia, JIMBEI, Paulina, DEATIŞEN, Victor. Tamiflu şi BioR în tratamentul pacienţilor cu gripă A (H1N1). In: Sănătate Publică, Economie şi Management în Medicină , 2012, nr. 5(44), pp. 83-86. ISSN 1729-8687.

EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core

Sănătate Publică, Economie şi Management în Medicină

Numărul 5(44) / 2012 / ISSN 1729-8687 /ISSNe 2587-3873

Tamiflu şi BioR în tratamentul pacienţilor cu gripă A (H1N1)

Tamiflu and BioR in treatment of patients with influenza A (H1N1

Тамифлу и БиоР в лечении больных гриппом A (H1N1)

Pag. 83-86

Pantea Valeriu¹, Rudic Valeriu¹, Spânu Constantin², Cebotarescu Valentin¹, Cojuhari Lilia¹, Jimbei Paulina³, Deatişen Victor³

¹ Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“,
² Centrul Naţional de Sanătate Publică,
³ Spitalul Clinic Republican de Boli Infecţioase „Toma Ciorbă“

Disponibil în IBN: 16 mai 2020

Descarcă PDF

Rezumat

A comparative study of combined Tamiflu and BioR treatment was performed în 22 patients with H1N1 infl uenza (an experimental lot) and 17 patients (control lot) în which was administered Tamifl u only. The diagnosis of A (H1N1) influenza was confi rmed by PCR. The Tamifl u and BioR combined treatment, opposite the monotherapy with Tamifl u, contributed to the decreasing of clinical symptomatology length, the admission length of patients with A (H1N1) infl uenza and the decreasing of hospitalization length of patients with brochopneumonia.

Под наблюдениием находились 22 больных с гриппом A (H1N1), экспериментальная группа, и 17 больных с тем же диагнозом, контрольная группа. В первой группе было назначено лечение Тамифлу и БиоР, а во второй группе – только Тамифлу. Диагноз гриппа A (H1N1) был подтвержден молекулярнобиологическим метотод (ПЦР). У больных, которые получали лечение Тамифлу и БиоР-ом (первая группа) длительность клинической симптоматики и пребывание в стационаре были в 2 раза меньше чем у больных второй группы, которые принимали только Тамифлу. Также уменьшилась длительность пребывания больных бронхопневмонией: в первой группе составила 5,2 дней, а во второй – 7 дней.

Cuvinte-cheie
A (H1N1) influenza, Tamiflu, BioR, treatment,

грипп A (H1N1), Тамифлу, БиоР, лечение

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-103815</cfResPublId>
<cfResPublDate>2012-09-01</cfResPublDate>
<cfVol>44</cfVol>
<cfIssue>5</cfIssue>
<cfStartPage>83</cfStartPage>
<cfISSN>1729-8687</cfISSN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/103815</cfURI>
<cfTitle cfLangCode='RO' cfTrans='o'>Tamiflu şi BioR &icirc;n tratamentul pacienţilor cu gripă A (H1N1)</cfTitle>
<cfKeyw cfLangCode='RO' cfTrans='o'>A (H1N1) influenza; Tamiflu; BioR; treatment; грипп A (H1N1); Тамифлу; БиоР; лечение</cfKeyw>
<cfAbstr cfLangCode='EN' cfTrans='o'><p>A comparative study of combined Tamiflu and BioR treatment was performed &icirc;n 22 patients with H1N1 infl uenza (an experimental lot) and 17 patients (control lot) &icirc;n which was administered Tamifl u only. The diagnosis of A (H1N1) influenza was confi rmed by PCR. The Tamifl u and BioR combined treatment, opposite the monotherapy with Tamifl u, contributed to the decreasing of clinical symptomatology length, the admission length of patients with A (H1N1) infl uenza and the decreasing of hospitalization length of patients with brochopneumonia.</p></cfAbstr>
<cfAbstr cfLangCode='RU' cfTrans='o'><p>Под наблюдениием находились 22 больных с гриппом A (H1N1), экспериментальная группа, и 17 больных с тем же диагнозом, контрольная группа. В первой группе было назначено лечение Тамифлу и БиоР, а во второй группе &ndash; только Тамифлу. Диагноз гриппа A (H1N1) был подтвержден молекулярнобиологическим метотод (ПЦР). У больных, которые получали лечение Тамифлу и БиоР-ом (первая группа) длительность клинической симптоматики и пребывание в стационаре были в 2 раза меньше чем у больных второй группы, которые принимали только Тамифлу. Также уменьшилась длительность пребывания больных бронхопневмонией: в первой группе составила 5,2 дней, а во второй &ndash; 7 дней.</p></cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-13417</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-244</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-11974</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-10924</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-10995</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-29209</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-35951</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-13417</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-13417-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
<cfFamilyNames>Pantea</cfFamilyNames>
<cfFirstNames>Valeriu</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-244</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-244-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
<cfFamilyNames>Rudik</cfFamilyNames>
<cfFirstNames>V.</cfFirstNames>
<cfFamilyNames>Рудик</cfFamilyNames>
<cfFirstNames>Валерий</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-11974</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11974-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
<cfFamilyNames>Spânu</cfFamilyNames>
<cfFirstNames>Constantin</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-10924</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-10924-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
<cfFamilyNames>Cebotarescu</cfFamilyNames>
<cfFirstNames>Valentin</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-10995</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-10995-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
<cfFamilyNames>Cojuhari</cfFamilyNames>
<cfFirstNames>Lilia</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-29209</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-29209-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
<cfFamilyNames>Jimbei</cfFamilyNames>
<cfFirstNames>Pavlina</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-35951</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-35951-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2012-09-01T24:00:00</cfStartDate>
<cfFamilyNames>Deatişen</cfFamilyNames>
<cfFirstNames>Victor</cfFirstNames>
</cfPersName_Pers>
</cfPers>
</CERIF>